{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:04:07Z","timestamp":1760299447820},"reference-count":45,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T00:00:00Z","timestamp":1478131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T00:00:00Z","timestamp":1478131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["80748301","2014-2271","521-2014-2057"],"award-info":[{"award-number":["80748301","2014-2271","521-2014-2057"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swedish Cancer Society [Cancerfonden]","award":["CAN 2013\/469","CAN 2009\/1175"],"award-info":[{"award-number":["CAN 2013\/469","CAN 2009\/1175"]}]},{"DOI":"10.13039\/501100006636","name":"FORTE","doi-asserted-by":"crossref","award":["2014-1962"],"award-info":[{"award-number":["2014-1962"]}],"id":[{"id":"10.13039\/501100006636","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007231","name":"Cancer Society in Stockholm","doi-asserted-by":"crossref","award":["141092"],"award-info":[{"award-number":["141092"]}],"id":[{"id":"10.13039\/501100007231","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Cancer"],"published-print":{"date-parts":[[2017,2,1]]},"DOI":"10.1002\/ijc.30476","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T15:32:56Z","timestamp":1476891176000},"page":"581-590","source":"Crossref","is-referenced-by-count":15,"title":["Differences in survival for patients with familial and sporadic cancer"],"prefix":"10.1002","volume":"140","author":[{"given":"Myeongjee","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics; Karolinska Institutet; Stockholm Sweden"},{"name":"Department of Occupational and Environmental Medicine, School of Medicine; Ewha Womans University; Seoul South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Reilly","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics; Karolinska Institutet; Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda Sofie","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Nutrition; Karolinska Institutet and University Hospital; Stockholm Sweden"},{"name":"Department of Surgery; University of California at San Francisco (UCSF); San Francisco C, A"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamila","family":"Czene","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics; Karolinska Institutet; Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,11,3]]},"reference":[{"key":"10.1002\/ijc.30476-BIB0001|ijc30476-cit-0001","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ijc.10764","article-title":"Familial risk of cancer by site and histopathology","volume":"103","author":"Hemminki","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.30476-BIB0002|ijc30476-cit-0002","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ijc.11478","article-title":"Familial risk of cancer: data for clinical counseling and cancer genetics","volume":"108","author":"Hemminki","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.30476-BIB0003|ijc30476-cit-0003","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1038\/leu.2012.103","article-title":"High risks of familial chronic lymphatic leukemia for specific relatives: signposts for genetic discovery?","volume":"26","author":"Rebora","year":"2012","journal-title":"Leukemia"},{"key":"10.1002\/ijc.30476-BIB0004|ijc30476-cit-0004","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1002\/ijc.29239","article-title":"Patterns of changing cancer risks with time since diagnosis of a sibling","volume":"136","author":"Lee","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.30476-BIB0005|ijc30476-cit-0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-3835(03)00420-8","article-title":"Allelic diversity in the host genetic background may be an important determinant in tumor metastatic dissemination","volume":"200","author":"Hunter","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1002\/ijc.30476-BIB0006|ijc30476-cit-0006","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S1470-2045(07)70282-6","article-title":"Familial concordance in cancer survival: a Swedish population-based study","volume":"8","author":"Lindstrom","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1002\/ijc.30476-BIB0007|ijc30476-cit-0007","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/annonc\/mdu270","article-title":"Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer","volume":"25","author":"Lindstrom","year":"2014","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1002\/ijc.30476-BIB0008|ijc30476-cit-0008","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1093\/hmg\/ddr228","article-title":"Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium","volume":"20","author":"Broeks","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1002\/ijc.30476-BIB0009|ijc30476-cit-0009","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1158\/0008-5472.CAN-08-0427","article-title":"Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies","volume":"68","author":"Apetoh","year":"2008","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.30476-BIB0010|ijc30476-cit-0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10552-004-6255-7","article-title":"Socio-economic factors and breast cancer survival-a population-based cohort study (Sweden)","volume":"16","author":"Lagerlund","year":"2005","journal-title":"Cancer Causes Control"},{"key":"10.1002\/ijc.30476-BIB0011|ijc30476-cit-0011","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/02841860701784544","article-title":"Survival in ovarian cancer patients by histology and family history","volume":"47","author":"Ji","year":"2008","journal-title":"Acta Oncol"},{"key":"10.1002\/ijc.30476-BIB0012|ijc30476-cit-0012","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/ijc.29062","article-title":"The prognostic value of family history among patients with urinary bladder cancer","volume":"136","author":"Egbers","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.30476-BIB0013|ijc30476-cit-0013","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-1-59745-423-0_10","article-title":"The Swedish multi-generation register","volume":"675","author":"Ekbom","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1002\/ijc.30476-BIB0014|ijc30476-cit-0014","unstructured":"National Board of Health and Welfare Swedish Cancer Registry http:\/\/www.socialstyrelsen.se\/register\/halsodataregister\/cancerregistret"},{"key":"10.1002\/ijc.30476-BIB0015|ijc30476-cit-0015","first-page":"1638","article-title":"Attributable risks of familial cancer from the family-cancer database","volume":"11","author":"Hemminki","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/ijc.30476-BIB0016|ijc30476-cit-0016","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1684\/bdc.2013.1789","article-title":"Glial and glioneuronal tumors in adults and children: main genetic alterations and towards a histomolecular classification","volume":"100","author":"Figarella-Branger","year":"2013","journal-title":"Bull Cancer"},{"key":"10.1002\/ijc.30476-BIB0017|ijc30476-cit-0017","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/ijc.28849","article-title":"Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006","volume":"135","author":"Leeuwen","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.30476-BIB0018|ijc30476-cit-0018","volume-title":"Cancer incidence in Sweden","author":"Center for Epidemiology","year":"2011"},{"key":"10.1002\/ijc.30476-BIB0019|ijc30476-cit-0019","first-page":"309","volume-title":"TNM classification of malignant tumours","author":"Sobin","year":"2010"},{"key":"10.1002\/ijc.30476-BIB0020|ijc30476-cit-0020","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/bjc.2013.411","article-title":"Low-dose aspirin use and cancer characteristics: a population-based cohort study","volume":"109","author":"Jonsson","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1002\/ijc.30476-BIB0021|ijc30476-cit-0021","unstructured":"Institute S. The SAS system for Windows. Release 9.2. Cary, NC SAS Inst 2011"},{"key":"10.1002\/ijc.30476-BIB0022|ijc30476-cit-0022","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/annonc\/mdv131","article-title":"Life expectancy of colon, breast, and testicular cancer patients: an analysis of US-SEER population-based data","volume":"26","author":"Capocaccia","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1002\/ijc.30476-BIB0023|ijc30476-cit-0023","first-page":"868","article-title":"Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom coordinating committee for cancer research (UKCCCR) familial ovarian cancer study group","volume":"59","author":"Pharoah","year":"1999","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.30476-BIB0024|ijc30476-cit-0024","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1200\/JCO.2011.35.3078","article-title":"Association of family history with cancer recurrence and survival in patients with gastric cancer","volume":"30","author":"Han","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1002\/ijc.30476-BIB0025|ijc30476-cit-0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejca.2015.09.015","article-title":"Survival in familial and non-familial breast cancer by age and stage at diagnosis","volume":"52","author":"Kharazmi","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1002\/ijc.30476-BIB0026|ijc30476-cit-0026","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2559.1992.tb01032.x","article-title":"Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up","volume":"20","author":"Ellis","year":"1992","journal-title":"Histopathology"},{"key":"10.1002\/ijc.30476-BIB0027|ijc30476-cit-0027","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1245\/s10434-010-0953-z","article-title":"Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes","volume":"17","author":"Wasif","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1002\/ijc.30476-BIB0028|ijc30476-cit-0028","first-page":"185","article-title":"Gastric cancer: correlation between clinicopathological factors and survival of patients (II)","volume":"50","author":"Lazar","year":"2009","journal-title":"Rom J Morphol Embryo"},{"key":"10.1002\/ijc.30476-BIB0029|ijc30476-cit-0029","first-page":"5355","article-title":"Histological subtypes of prostatic cancer: a comparative survival study","volume":"17","author":"Kendal","year":"2010","journal-title":"Can J Urol"},{"key":"10.1002\/ijc.30476-BIB0030|ijc30476-cit-0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/jns.1998.88.1.0001","article-title":"Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on surveillance, epidemiology, and end results (SEER) data, 1973-1991","volume":"88","author":"Davis","year":"1998","journal-title":"J Neurosurg"},{"key":"10.1002\/ijc.30476-BIB0031|ijc30476-cit-0031","volume-title":"SEER cancer statistics review","year":"2014"},{"key":"10.1002\/ijc.30476-BIB0032|ijc30476-cit-0032","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/jnci\/djs272","article-title":"Mammography screening and breast cancer mortality in Sweden","volume":"104","author":"Autier","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/ijc.30476-BIB0033|ijc30476-cit-0033","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1200\/JCO.2006.05.7661","article-title":"Aggressiveness of familial prostate cancer","volume":"24","author":"Kupelian","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1002\/ijc.30476-BIB0034|ijc30476-cit-0034","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.juro.2006.07.159","article-title":"Characteristics of patients with familial versus sporadic prostate cancer","volume":"176","author":"Roehl","year":"2006","journal-title":"J Urol"},{"key":"10.1002\/ijc.30476-BIB0035|ijc30476-cit-0035","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/S0022-5347(05)00698-1","article-title":"Prevalence, treatment modalities and prognosis of familial prostate cancer in a screened population","volume":"175","author":"Roemeling","year":"2006","journal-title":"J Urol"},{"key":"10.1002\/ijc.30476-BIB0036|ijc30476-cit-0036","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/ijc.25846","article-title":"Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden","volume":"129","author":"Jonsson","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.30476-BIB0037|ijc30476-cit-0037","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/jnci\/djp001","article-title":"Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context","volume":"101","author":"Draisma","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/ijc.30476-BIB0038|ijc30476-cit-0038","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1182\/blood-2013-05-501312","article-title":"No familial aggregation in chronic myeloid leukemia","volume":"122","author":"Bjorkholm","year":"2013","journal-title":"Blood"},{"key":"10.1002\/ijc.30476-BIB0039|ijc30476-cit-0039","first-page":"416","article-title":"Family clustering of blood cancers as a risk factor for lymphoid neoplasms","volume":"90","author":"Domingo-Domenech","year":"2005","journal-title":"Haematologica"},{"key":"10.1002\/ijc.30476-BIB0040|ijc30476-cit-0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1200\/JCO.2011.37.1203","article-title":"Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes","volume":"30","author":"Goldin","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1002\/ijc.30476-BIB0041|ijc30476-cit-0041","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/humu.22489","article-title":"Germline mutations of inhibins in early-onset ovarian epithelial tumors","volume":"35","author":"Tournier","year":"2014","journal-title":"Hum Mutat"},{"key":"10.1002\/ijc.30476-BIB0042|ijc30476-cit-0042","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/cncr.20138","article-title":"Familial association of specific histologic types of ovarian malignancy with other malignancies","volume":"100","author":"Lorenzo Bermejo","year":"2004","journal-title":"Cancer"},{"key":"10.1002\/ijc.30476-BIB0043|ijc30476-cit-0043","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1002\/cncr.26655","article-title":"Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer","volume":"118","author":"Hyman","year":"2012","journal-title":"Cancer"},{"key":"10.1002\/ijc.30476-BIB0044|ijc30476-cit-0044","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10689-006-9112-x","article-title":"Improved survival in BRCA2 carriers with ovarian cancer","volume":"6","author":"Pal","year":"2007","journal-title":"Familial Cancer"},{"key":"10.1002\/ijc.30476-BIB0045|ijc30476-cit-0045","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s10552-010-9643-1","article-title":"Australian women's awareness of ovarian cancer symptoms, risk and protective factors, and estimates of own risk","volume":"21","author":"Jones","year":"2010","journal-title":"Cancer Causes Control"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.30476","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.30476","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/ijc.30476\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T21:20:26Z","timestamp":1625174426000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.30476"}},"subtitle":["Patients with familial and sporadic cancer"],"short-title":[],"issued":{"date-parts":[[2016,11,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ijc.30476","archive":["Portico"],"relation":{},"ISSN":["0020-7136"],"issn-type":[{"value":"0020-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11,3]]}}}